Oncology Experts

Xiaoling Xu

Associate Professor
Health science
University of Macau


Xiaoling XU received his Bchelor's degree from Department of Biology, West China Normal University and Master's from Institute of Hydrobiology, Academia Sinica, Wuhan, China (1987). He earned his Ph.D. from Department of Physiology, University of Maryland Medical School, Baltimore, USA in 2002.

Research Interest

Tumor, Breast cancer


  • Xiaoling Xu, Beeta Ehdaie, Nobuya Ohara, Tadashi Yoshino, and Chu-Xia Deng (2010). Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice. Oncogene, 4;29(5):674-86.

  • Su N*, Xiaoling Xu * (Equal contribution), Li C, He Q, Zhao L, Li C, Chen S, Luo F, Yi L, Du X, Huang H, Chu-Xia Deng*, Chen L* (Corresponding author). (2010). Generation of Fgfr3 conditional knockout mice, Int J Biol Sci. 6(4):327-32.

  • Seung Min Jeong, Cuiying Xiao, Lydia W.S Finley, Tyler Lahusen, Amanda L. Souza, Kerry Pierce, Ying-Hua Li, Xiaoxu Wang, GaĆ«lle Laurent, Natalie J. German, Xiaoling Xu, Cuiling Li, Rui-Hong Wang, Jaewon Lee, Alfredo Csibi, Richard Cerione, John Blenis, Clary B. Clish, Alec Kimmelman, Chu-Xia Deng* (Corresponding authors) & Marcia C. Haigis* (Corresponding authors) (2013). SIRT4 is a tumor suppressor that regulates cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell, 23(4):450-63.

Global Experts from Macao

Global Experts in Subject

Share This Profile
Recommended Conferences